XIUYI

8/21/2026 · Premium Health Screening in Tokyo

One tumor marker came back slightly high. Does that mean cancer?

An upward arrow is not a diagnosis. It is not an all-clear either. These markers were never designed to diagnose anything. There is only one right way to use them: read them alongside your imaging results and your own previous numbers.

It is 3 a.m. and the report is spread out on the bed. You flipped through the first few pages quickly. All normal. Then, on the blood test page, an abbreviation followed by an upward arrow. You typed the abbreviation into a search bar, and the first screen was all about one type of cancer. You kept scrolling. Some people wrote, "Mine was high too, and it turned out to be nothing." Others wrote, "I didn't take it seriously at the time."

That night will probably be a hard one. But what you need the next morning is not reassurance. It is an order of steps: how to use this number from here.

1. What these markers are actually for

Tumor markers are substances in the blood that can be measured. Some tumors can make them rise, but tumors are not the only cause. Some benign conditions, inflammation, normal physiological states, and even differences in testing methods can make them fluctuate.

Their most established use is actually tracking change in people who have already been diagnosed: before and after treatment, before and after follow-up, a rise or fall in the same marker means something. When used to screen healthy people without symptoms, a single marker on its own tells you much less. (PSA for prostate cancer is one of the few exceptions whose screening value is discussed on its own terms, and whether to test and how to read it is still something to discuss with a doctor.)

This is not our own claim. It is printed in the clinics' own test descriptions. In the add-on test descriptions of one clinic we work with, the gynecologic tumor marker entry says "a single marker cannot confirm a diagnosis; must be combined with imaging." The lung tumor marker entry says "for risk reference only; may also rise in some benign conditions." The pancreas entry says "also a tumor marker; interpret together with imaging."

2. First, find out exactly which markers you were tested for

A lot of confusion comes from a more basic problem: different reports list completely different test names.

Take the public materials from two health check centers we have on hand. At one (Fujita Health University Haneda Clinic, April 2026 price list), the tumor marker section of the standard package includes CEA, CA19-9, AFP and SCC, plus PSA for men and CA125 for women. The other (TIMC TOKYO, Ver.4.0, April 14, 2026 price list, all prices including tax) prices them as a separate set: the men's set is JPY 29,100 and includes CEA, AFP, CA19-9, CYFRA, ProGRP, PSA and IL-2; the women's set is JPY 33,000 and adds CA125 and SCC.

The add-on menu also lets you add markers by area, and the prices are not high (Fujita Health University Haneda Clinic, April 2026 price list, including tax): a lung set for JPY 16,500 (CYFRA / ProGRP / NSE), a pancreas set for JPY 14,300 (SPan-1 / DUPAN-2), and a gynecologic set for JPY 9,900 (CA15-3).

So when two reports show different arrows, sometimes it is simply because different markers were tested. Before you worry about one of them, check whether it is a marker you were not tested for at all last year.

3. After you see the arrow, the right order is three steps

Step 1: Look at how high it is, and even more, at the trend. Slightly above the upper limit of the reference range and several times above it are two completely different situations. And more valuable than the size of a single result is the trend: what the same marker was last year, and what it is this year. Having no previous number to compare with is the real problem most people face at this moment. That is why the action in the last section is worth doing today.

Step 2: Check whether the other results in the same report line up. A full health check includes more than blood tests: ultrasound, CT, endoscopy and more. When a doctor sees this arrow, the first thing they do is check whether the imaging of the corresponding area shows a matching finding. One line of numbers on its own carries far less information than that same line read together with imaging.

Step 3: The doctor decides whether to repeat the same marker after some time or go straight to a targeted test. There is no general answer for this step. How long to wait and what to add depends on how high it is, the trend, your age and your medical history. Your treating doctor decides based on your complete records. This article is not individual medical advice.

4. Three things we do not recommend doing right now

This section does not work in our favor, but it is the most useful part of this article.

First, we do not recommend booking the most expensive test on your own. Seeing one marker slightly high and booking a whole-body PET-CT yourself (JPY 171,600 as a single test, including tax) is, in many cases, not the best move at this stage. Different tests look at different things, and a targeted test is usually cheaper and better matched to the question. As an example of direction only: for the pancreas, MRCP (an MRI of the pancreatic and bile ducts) is non-invasive and costs JPY 81,400. But whether you need it, when, and which test to choose is for your treating doctor to decide, not one line of numbers and one search.

Second, we do not recommend immediately retesting at a different facility and comparing the two numbers directly. Different labs may use different methods and reference ranges, so the two numbers may not be comparable. If you retest, go back to the same facility and the same method where possible.

Third, we do not recommend buying a whole new health check package because of this one marker. If the goal is only to recheck this marker, what you need is a targeted blood draw or one imaging test, not a full package in the JPY 593,800 to JPY 1,144,000 range.

5. The opposite case: all normal does not mean ruled out

This matters just as much, and it is said even less often:

Some cancers do not raise these markers in their early stages. So "all tumor markers normal" cannot be read as "ruled out." Markers cannot replace imaging and endoscopy. Those look at shape and at the mucosa itself, which is a different kind of information.

Someone whose report has every arrow pointing down and someone whose report has one arrow pointing up actually need the same thing: to read this page together with the other pages.

6. Next step: dig out last year's report today

You can finish this tonight, and it will help more than any search:

  • Find last year's (or an earlier) health check report and locate the same marker.
  • Copy both values, the reference ranges, the testing facilities and the report dates onto one sheet of paper or one note. Two points make a line. The trend is the most valuable information right now, and it can only come from old reports you kept yourself.
  • If you cannot find an old report, copy down this result, its reference range, the testing facility and the date exactly as they appear, and keep it safe. It is what you will need most this time next year, and the one thing you can do today for your future self.
  • Take that sheet to a doctor and ask three questions: How should a result this high be handled? When should I recheck, and which markers? Does this match the imaging results in the same report?

If you have a report you cannot make sense of, you can send it to us (remove your name, ID number and other identifying details). We will mark which markers were tested this time and which ones were never tested in last year's report. Often, that step alone explains the arrow that seemed to appear out of nowhere. You do not need to choose a clinic first, and you do not need to pay anything.

#elevated tumor markers#high CEA level#CA19-9 elevated#health check results explained

Related service: Premium Health Screening in Tokyo